Merck Kgaa, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MAGNESIUM CHLORIDE HEXAHYDRATE, with a corresponding US DMF Number 17834.
Remarkably, this DMF maintains an Active status since its submission on November 16, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 10, 2018, and payment made on May 05, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II